By Rady Ananda
Food Freedom News
The US Food & Drug Admin. just approved a drug made from genetically modified carrots to treat Gaucher, a rare disease found mostly among Ashkenazi Jews. Out of a global population of 6.8 billion, an estimated range of 600,000 to a million carry the recessive gene for it, though not all are symptomatic.
The incidence of Gaucher is so rare, in fact, that to approve a GMO carrot for this purpose makes no sense, raising the specter of some unstated plan.
As expected when humans ingest active foreign DNA, one of the side effects of the FDA-approved drug, Elelyso®, is anaphylactic shock, among other allergic reactions.